This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Resumen de acción LHCG
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Competidores de LHC Group, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$169.81 |
| 52 Week High | US$169.84 |
| 52 Week Low | US$115.32 |
| Beta | 0.42 |
| 1 Month Change | 3.76% |
| 3 Month Change | 0.91% |
| 1 Year Change | 32.12% |
| 3 Year Change | 30.61% |
| 5 Year Change | 178.06% |
| Change since IPO | 893.04% |
Noticias y actualizaciones recientes
Recent updates
LHC Group GAAP EPS of $0.35 misses by $0.95, revenue of $576.2M misses by $29.82M
Aug 03LHC Group: UnitedHealth Merger Is Worth Playing
Jul 19FTC second request in LHC Group/UnitedHealth said to probe pay, labor market
Jul 06These 4 Measures Indicate That LHC Group (NASDAQ:LHCG) Is Using Debt Safely
Feb 24
With EPS Growth And More, LHC Group (NASDAQ:LHCG) Is Interesting
Feb 06LHC Group (NASDAQ:LHCG) Has A Rock Solid Balance Sheet
Nov 25Is Now The Time To Put LHC Group (NASDAQ:LHCG) On Your Watchlist?
Nov 07Why We Think Shareholders May Be Considering Bumping Up LHC Group, Inc.'s (NASDAQ:LHCG) CEO Compensation
Jun 03LHC Group, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 10With EPS Growth And More, LHC Group (NASDAQ:LHCG) Is Interesting
Mar 25Are LHC Group, Inc.'s (NASDAQ:LHCG) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 07Is LHC Group, Inc. (NASDAQ:LHCG) Trading At A 45% Discount?
Feb 17Does LHC Group (NASDAQ:LHCG) Have A Healthy Balance Sheet?
Feb 04
LHC Group, Inc. (NASDAQ:LHCG) Insiders Have Been Selling
Jan 19Here's Why LHC Group's (NASDAQ:LHCG) Statutory Earnings Are Arguably Too Conservative
Jan 06Here's Why We Think LHC Group (NASDAQ:LHCG) Is Well Worth Watching
Dec 24Did You Miss LHC Group's (NASDAQ:LHCG) Whopping 338% Share Price Gain?
Dec 12LHC Group, Inc. (NASDAQ:LHCG) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 30Estimating The Fair Value Of LHC Group, Inc. (NASDAQ:LHCG)
Nov 18LHC Group, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 09Rentabilidad de los accionistas
| LHCG | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 0.6% | 6.5% | -3.2% |
| 1Y | 32.1% | 4.0% | 19.3% |
Rentabilidad vs. Industria: LHCG exceeded the US Healthcare industry which returned -0.3% over the past year.
Rentabilidad vs. Mercado: LHCG exceeded the US Market which returned -9% over the past year.
Volatilidad de los precios
| LHCG volatility | |
|---|---|
| LHCG Average Weekly Movement | 2.1% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: LHCG has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: LHCG's weekly volatility (2%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1994 | 23,000 | Keith Myers | www.lhcgroup.com |
Resumen de fundamentos de LHC Group, Inc.
| Estadísticas fundamentales de LHCG | |
|---|---|
| Capitalización bursátil | US$5.29b |
| Beneficios(TTM) | US$39.87m |
| Ingresos (TTM) | US$2.28b |
132.7x
Ratio precio-beneficio (PE)2.3x
Ratio precio-ventas (PS)¿Está LHCG sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de LHCG | |
|---|---|
| Ingresos | US$2.28b |
| Coste de los ingresos | US$1.40b |
| Beneficio bruto | US$883.61m |
| Otros gastos | US$843.74m |
| Beneficios | US$39.87m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 1.28 |
| Margen bruto | 38.71% |
| Margen de beneficio neto | 1.75% |
| Ratio deuda/patrimonio | 43.0% |
¿Cómo se ha desempeñado LHCG a largo plazo?
Ver rendimiento histórico y comparativa